Search

everythinglearnresearchcommunity

for

Search:↓

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Skin issues are common and important for diagnosing PCOS.

A new gene mutation causes insulin resistance in a girl and her mother.

Vitamin D levels are not linked to Alopecia Areata.

People with vitiligo tend to have lower vitamin D levels.

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

There's no significant link between blood fat levels and male pattern baldness.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

A protein-sparing modified fast can help with short-term weight loss if supervised by a doctor.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.